Finance

Lists
Why is 600812 down 4,72%?
Dive Deeper
600812:SHA
North China Pharmaceutical Co Ltd
6,26 CN¥
-4,72%
(-0,31) 1D
16 հոկ, 15:00:00 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600812...
Open
6,33 CN¥
High
6,90 CN¥
Low
6,10 CN¥
Avg. vol.
61,12 մլն
Volume
307,76 մլն
Dividend
0,56%
Quarterly dividend
0,01 CN¥
Ex-dividend date
11 հնս, 2026 թ.
P/E ratio
87,26
52-wk high
6,90 CN¥
52-wk low
4,11 CN¥
EPS
0,07 CN¥
Shares outstanding
1,63 մլրդ
No. of employees
10 հզր
Open
6,33 CN¥
High
6,90 CN¥
Low
6,10 CN¥
Avg. vol.
61,12 մլն
Volume
307,76 մլն
Dividend
0,56%
Quarterly dividend
0,01 CN¥
Ex-dividend date
11 հնս, 2026 թ.
P/E ratio
87,26
52-wk high
6,90 CN¥
52-wk low
4,11 CN¥
EPS
0,07 CN¥
Shares outstanding
1,63 մլրդ
No. of employees
10 հզր
News stories
From web sources and news partners
Profile
North China Pharmaceutical Group Corp., is a pharmaceutical manufacturer in China. NCPC was one of the key construction projects during China's First Five-Year Plan. After five years of construction since the foundation date in June 1953, the first successful pharmaceutical production, started in June 1958. Being one of the antibiotic producers both in technology and production scale at that time, NCPC created a history of commercial production of antibiotics in China. It has 45 years of development experience. NCPC has been taking the lead in the Chinese pharmaceutical industry in key economic indexes, ranked as one of the Top500 Enterprises and the best profit-makers in China. By the end of 2002, the total assets of the company were valued at US$2 billion, with 18,500 employees. In 2002, NCPC claimed a domestic sales revenue of US$700 million and export sales of US$100 million. Wikipedia
About North China Pharmaceutical Co Ltd
CEO-
Employees9,97 հզր
Founded20 դեկ, 1992 թ.
Headquarters-
Sector-
Website-
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
2,21 մլրդ
1,76 մլրդ
2,15 մլրդ
2,07 մլրդ
Cost of goods sold
1,59 մլրդ
1,07 մլրդ
1,53 մլրդ
1,54 մլրդ
Cost of revenue
1,59 մլրդ
1,07 մլրդ
1,53 մլրդ
1,54 մլրդ
Research and development expenses
85,19 մլն
85,95 մլն
95,62 մլն
84,71 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
419,54 մլն
414,91 մլն
354,22 մլն
304,68 մլն
Operating expense
504,74 մլն
539,54 մլն
495,25 մլն
396,76 մլն
Total operating expenses
2,09 մլրդ
1,61 մլրդ
2,03 մլրդ
1,94 մլրդ
Operating income
116,01 մլն
149,57 մլն
128,11 մլն
125,58 մլն
Other non operating income
-299,86 հզր
-2,96 մլն
-10,58 մլն
6,02 մլն
EBT including unusual items
73,18 մլն
70,19 մլն
66,28 մլն
57,65 մլն
EBT excluding unusual items
45,54 մլն
84,31 մլն
61,80 մլն
58,08 մլն
Income tax expense
23,93 մլն
24,28 մլն
16,90 մլն
16,15 մլն
Effective tax rate
32,70%
34,59%
25,50%
28,02%
Other operating expenses
4,82 մլն
29,30 մլն
27,82 մլն
15,57 մլն
Net income
35,01 մլն
24,55 մլն
35,47 մլն
28,37 մլն
Net profit margin
1,58%
1,40%
1,65%
1,37%
Earnings per share
-
-
-
-
Interest and investment income
19,41 մլն
27,71 մլն
19,26 մլն
22,40 մլն
Interest expense
-85,85 մլն
-85,06 մլն
-74,99 մլն
-76,52 մլն
Net interest expenses
-66,43 մլն
-57,35 մլն
-55,73 մլն
-54,13 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
313,14 մլն
371,92 մլն
350,45 մլն
367,38 մլն
Gain or loss from assets sale
-9,85 հզր
-827,34 հզր
-
-217,80 հզր
AI content may include mistakes. Learn more
Google Apps